TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Difficulties in Emotion Regulation Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: BMD of lumbar spine (L2-4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: BMD of femoral neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: Prevalence of asexual Plasmodium falciparum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of infectious feeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Duration of time to complete recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of muscle tremors
Endpoint domain: Adverse events/effects
Primary endpoint: Premature luteinizing hormone surge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Mean number of follicles on trigger day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Mean number of M2 oocytes retrieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Mean number of good quality day-3 embryos
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: mean offset yield force
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Caries diagnosis effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success and survival rate
Endpoint domain: Mortality/survival
Primary endpoint: occlusal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: affective expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: social reciprocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Off-label use of rituximab
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention of AMH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sound Pressure Level (SPL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Utterance lengths (syllables per breath group)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Lung volume termination levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: LLL of the target lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score of knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Awareness rates of the disease, attitude, and behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Measurement of staff, environmental, and resident outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of CVD/HHF
Endpoint domain: Mortality/survival
Primary endpoint: Risk of MI and ischaemic stroke
Endpoint domain: Mortality/survival
Primary endpoint: need for respiratory assistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: need for inotropes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: initiation of postpartum contraception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in hospitalisations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: problematic symptoms for residents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved staff skills and confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Influence of cost on treatment decision
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Performance increase on AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in parent‐rated SDQ total difficulties scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective burden reduction
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Correlation of Teherán-Morales's scale with subjective assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 24-h glucose level changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: combined compression score ≥70%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delivery costs of implemented practices
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in citations at 1 year
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Association of insomnia with cardiovascular disease outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of moderate-severe pain of the posterior knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores of the posterior knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction for pain management
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morphological characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: visuospatial memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Words per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in compensatory errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in nasal emission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for hysteroscopy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Visual analog scale score for office aspiration
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: intracerebral hemorrhage (ICH)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean OBL score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean dissection score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral Mucositis (OM) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of ART non-persistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perioperative hemoglobin level (HBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: decline of hemoglobin (ΔHb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: allogeneic blood transfusion (ABT) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Grade 1 myelitis incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 1 central nervous system necrosis incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 2 optic nerve disorder incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Diabetes medication use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Improvement in reintegration
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Cancellation Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EF Recurrence Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of complete HDP
Endpoint domain: Adverse events/effects
Primary endpoint: median reduction in forced vital capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Primary cardiovascular end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 30-day composite of progression to severe COVID-19 disease
Endpoint domain: Mortality/survival
Primary endpoint: remission prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTV prediction accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in chronic rhinitis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: facial wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: high-concentration collagen-induced platelet aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Bleeding Academic Research Consortium type 2 or higher bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Mean TSS change after 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median nerve motor distal latency (mMDL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: median sensory nerve conduction velocity (mSNCV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: adjusted improvement in knowledge score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: percentage of youth reporting any alcohol use is risky/dangerous
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: predicted mean frequency of drinking days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anesthetic site discomfort
Endpoint domain: Adverse events/effects
Primary endpoint: Leakage complications
Endpoint domain: Adverse events/effects
Primary endpoint: VLDL triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: birth weight (BW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time in hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: glycemic variability (GV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychotropic medication usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPSD symptomatology improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: necrotising enterocolitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reported positive COVID-19 test result
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease in density of microcolumns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in cosmetic outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to diagnose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: survival rate among demented patients
Endpoint domain: Mortality/survival
Primary endpoint: 2 km rowing performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of interferon‐γ, IL‐4, IL‐17, pentraxin 3, NO, and IL‐10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: emotion regulation abilities
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: toe flexor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: passive kinesthesia threshold of ankle eversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional capacity (METS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pancreatic polypeptide (PP) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: inflammatory grades
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scar visibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal UA pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vellus hair reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Ca(OH)2 elimination from root canals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0‐∞ of metoclopramide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recognition of AEBS conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time in hypoglycaemia (54 to <70 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time in range (TIR 70-180 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glycaemic Response Index (GRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: overall weight loss after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of CIN2+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time to reach peak serum concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall mean transformed Detsky score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nipple sensitivity to pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lubrication domain of the FSFI
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Orgasm domain of the FSFI
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AAC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: lipoprotein (a)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of primary composite endpoint (cardiac death, nonfatal myocardial infarction and urgent revascularization)
Endpoint domain: Mortality/survival
Primary endpoint: RSV A2 neutralization geometric mean titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: RSV infection confirmed cases
Endpoint domain: Adverse events/effects
Primary endpoint: Chemotherapy-induced fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: canine distalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cancellous bone density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PedsQL GI symptoms scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Constipation sub-scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bristol stool form
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cancer progression (CP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: PSA levels at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricle (LV) untwist rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: FMMS-LL score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in knowledge of contour lines
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: intention to monitor/read social interactive technology while driving
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: rejection
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: TPE likelihood
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Volume of root dentine removed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall sustained virologic response at post‐treatment Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of primary care-based follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of PSA progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eczema severity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental self-efficacy improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Antepartum Gastrointestinal Symptom Assessment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: NRS scores during awakening period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ulnar-radial pressure differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ulnar-radial force differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: YBOCS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle temperature reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in logarithmic FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of severe or very severe exacerbations
Endpoint domain: Adverse events/effects
Primary endpoint: Knowledge of WHO physical activity guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Promotion of physical activities in routine practice
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Attitude towards physical activity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increased twice‐daily toothbrushing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fewer caries developed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total motor AIMS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of KS tumor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Accuracy of fluid delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of ischemic vascular event
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of sedentary behavior (SB) time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total internal rotation-external rotation (IR-ER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean medial-lateral translation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: GA perimeter-adjusted growth rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Care Agency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sexual health literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pregnancy prevention behavior
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Sexual risk behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unintentional PG excision rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Risk of parathyroid tissue presence in the specimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of re-presentation at 72 hours and 2 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased UGE24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Gains in daily stepping
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Gains in endurance (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain responses to visual food stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: psychometric parameters of appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GMIM response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subfoveal CT values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: submacular CVI values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: hospitalization rate in ICU
Endpoint domain: Mortality/survival
Primary endpoint: Intubation times (seconds)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: displacement of fixation methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rey auditory verbal learning (RAVL) test total recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Long delayed recall scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Face-name associations scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes